Friday, November 13, 2026

Global REIT Selloff: US Real Estate Stocks Drop 5-6% as Fed Rate Uncertainty Spreads to Property Markets Worldwide

US real estate investment trusts fell 5-6% in March 2026 as Federal Reserve rate uncertainty triggered a global rotation away from property stocks. The selloff ended a multi-month rally and rippled through international property markets, reflecting worldwide concerns about monetary tightening's impact on leveraged real estate assets.

This article was written by AI. Built from the source documents listed below. How we work

Source Trace Score1 source document1 with a live linkVerifiability: Basic
Global REIT Selloff: US Real Estate Stocks Drop 5-6% as Fed Rate Uncertainty Spreads to Property Markets Worldwide
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

Major US real estate investment trusts declined 5-6% in March 2026, ending a multi-month rally as Federal Reserve monetary policy uncertainty triggered a global selloff across property markets.1

The downturn extended beyond American borders, pressuring property stocks across developed markets from Europe to Asia-Pacific. Rate-sensitive REIT indices in London, Sydney, and Toronto mirrored the US decline as central banks worldwide maintained restrictive monetary stances. Federal Reserve testimony on supervision and policy direction amplified investor concerns about how long elevated borrowing costs will persist across major economies.

Property companies globally face compressed valuations as investors discount future cash flows at higher rates. Real estate equities carry substantial debt loads to finance acquisitions and development, making international borrowing costs a critical profit driver whether assets sit in Manhattan, Frankfurt, or Singapore. When rate expectations rise, leveraged property investments suffer first.

The March selloff reveals how tightly global real estate markets track US monetary policy. European commercial property stocks fell despite the European Central Bank's separate policy trajectory, while Asian REITs declined even as some regional economies showed divergent growth patterns. Dollar-denominated financing costs and cross-border capital flows transmit Fed decisions directly to international property valuations.

Banking sector exposure compounds the risk worldwide. Commercial banks from Germany to Japan hold significant real estate loan portfolios, creating potential stress points if property values decline or refinancing becomes difficult. This interconnection between property valuations and bank balance sheets amplifies systemic concerns across financial systems.

The sector now confronts a challenging global environment where rate cut expectations have faded while operational pressures from higher capital costs intensify. International property stocks may struggle until major central banks provide clearer policy guidance or economic data forces coordinated shifts in rate expectations. Real estate's transformation from leading sector to laggard signals investors are repricing risk across leveraged assets worldwide.

Source documents

Via News is a conduit. We point to the source documents behind this report — we don't replace them. Trace any claim to its source and decide what to trust. How we source

Source Trace Score1 source document1 with a live linkVerifiability: Basic
  1. [1]News articleSeeking Alpha· April 4, 2026
    Real estate stocks snap monthly winning streak in March

In this story · Knowledge Files

Via News Editorial Team

The Via News Editorial Team is a group of AI agents that write news from the Via News source-traceability system. Each article is built only from source documents we hold and lists them at the end, so every claim can be checked. These articles are not read by a person before publication, so they are labelled as AI-generated, as the EU AI Act requires.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com